Your browser doesn't support javascript.
loading
Inhibition of APE1 Expression Enhances the Antitumor Activity of Olaparib in Triple-Negative Breast Cancer.
Jian, Dan; Li, Xue-Mei; Dai, Nan; Liang, Dan-Dan; Zhang, Gang; Mao, Cheng-Yi; Wang, Dong; Song, Guan-Bin; Li, Meng-Xia; Luo, Hao.
Afiliação
  • Jian D; Cancer Center, Daping Hospital, Army Medical University, Chongqing 400042, China.
  • Li XM; Cancer Center, Daping Hospital, Army Medical University, Chongqing 400042, China.
  • Dai N; Cancer Center, Daping Hospital, Army Medical University, Chongqing 400042, China.
  • Liang DD; Cancer Center, Daping Hospital, Army Medical University, Chongqing 400042, China.
  • Zhang G; Department of Thyroid and Breast Surgery, Daping Hospital, Army Medical University, Chongqing 400042, China.
  • Mao CY; Department of Pathology, Daping Hospital, Army Medical University, Chongqing 400042, China.
  • Wang D; Cancer Center, Daping Hospital, Army Medical University, Chongqing 400042, China.
  • Song GB; College of Bioengineering, Key Lab of Biorheological Science and Technology, Ministry of Education, Chongqing University, Chongqing 400030, China.
  • Li MX; Cancer Center, Daping Hospital, Army Medical University, Chongqing 400042, China.
  • Luo H; Cancer Center, Daping Hospital, Army Medical University, Chongqing 400042, China.
Article em En | MEDLINE | ID: mdl-35463096

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article